CRDF Cardiff Oncology, Inc.
Healthcare$1.97+0.00%OpenMarket Cap: $134.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.51
P/S
231.81
EV/EBITDA
-2.49
DCF Value
$0.02
FCF Yield
-30.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-2147.8%
Operating Margin
-9033.9%
Net Margin
-8527.2%
ROE
-95.5%
ROA
-91.0%
ROIC
-134.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $41.0K | -439.0% | $-12.8M | $-12.4M | $— | — |
| Q4 null | $243.0K | 100.0% | $-7.8M | $-7.2M | $— | — |
| FY null | $593.0K | 100.0% | $-49.0M | $-45.9M | $— | — |
| Q3 null | $120.0K | 100.0% | $-12.0M | $-11.3M | $— | — |
| Q2 null | $121.0K | -9470.2% | $-14.8M | $-13.9M | $— | — |
| Q1 null | $109.0K | 100.0% | $-14.4M | $-13.4M | $— | — |
| Q4 null | $151.0K | 100.0% | $-12.6M | $-11.8M | $— | — |
| FY null | $683.0K | 100.0% | $-48.7M | $-45.4M | $— | — |
| Q3 null | $165.0K | -5742.4% | $-12.6M | $-11.9M | $— | — |
| Q2 null | $163.0K | 35.6% | $-12.5M | $-11.8M | $— | — |
| Q1 null | $205.0K | 50.2% | $-10.9M | $-10.0M | $— | — |
| Q4 2023 | $156.0K | 34.0% | $-10.3M | $-9.3M | $-0.21 | — |